Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC)

SIMPLE SUMMARY: We investigate the use of the small molecule epigenetic modulator 4SC-202 as a potential cancer therapeutic or adjuvant for Triple Negative Breast Cancer (TNBC). Epigenetic modulation involves alteration of the cellular phenotype without altering the genotype. Here, we investigate ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zylla, Jessica L. S., Hoffman, Mariah M., Plesselova, Simona, Bhattacharya, Somshuvra, Calar, Kristin, Afeworki, Yohannes, de la Puente, Pilar, Gnimpieba, Etienne Z., Miskimins, W. Keith, Messerli, Shanta M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996906/
https://www.ncbi.nlm.nih.gov/pubmed/35406526
http://dx.doi.org/10.3390/cancers14071753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996906/
https://www.ncbi.nlm.nih.gov/pubmed/35406526
http://dx.doi.org/10.3390/cancers14071753

Ejemplares similares